Background: Taste is the characteristic sensory modality of the gustatory system associated with dietary intake. The ability of humans to perceive different tastes is predisposed by the activity of taste receptors. The expression of TAS1R family of genes enables the detection of sweetness and umaminess, whereas TAS2R enables the detection of bitterness. The varying levels of expression of these genes within different organs of the gastro-intestinal tract, regulates the metabolism of biomolecules including carbohydrates and proteins. Variations in the gene encoding for taste receptors might affect its binding affinity to tastant molecules and thereby pertain to varying degrees of sensation to taste among individuals. Aim: The goal of this review is to highlight the significant role of TAS1R and TAS2R as a potential biomarker to identify the incidence of morbidities and its probable onset. Method: We thoroughly investigated the SCOPUS, PubMed, Web of Science and Google Scholar databases for literature relating to the association between TAS1R and TAS2R receptors in highlighting the genetic variation during various health morbidities. Results: It has been shown that the abnormalities in taste perception restrain an individual from consuming the adequate amount of food. Taste receptors not only influence the dietary habits but also determine different aspects of human health and well-being. Conclusion: According to the available evidence the dietary molecules conferring varying taste modalities are observed to have therapeutic significance apart from its nutritive value. The taste associated incongruous dietary pattern is a risk factor for various morbidities including obesity, depression, hyperglyceridaemia, and cancers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.